27 February 2008
The effect of 30 Hz vs. 50 Hz passive vibration and duration of vibration on skin blood flow in the arm
Colleen Maloney-HindsABCDEF, Jerrold Scott PetrofskyABCDEF, Grenith ZimmermanACDEMed Sci Monit 2008; 14(3): CR112-116 :: ID: 836575
Abstract
Background
Recently, researchers have demonstrated that Whole Body Vibration (WBV) results in significant increases in skin blood flow (SBF). No study has determined if a specific frequency or a specific duration is better at optimizing SBF.
Material and Method
Two studies were conducted to determine, 1) if there is a difference in SBF due to passive vibration of the forearm at 30 Hz vs. 50 Hz, 2) if one frequency is superior, and 3) if there is an optimal duration. In the first study, 18 subjects (mean age 20.3+/-2.9 years) were randomly placed into a 30 Hz or 50 Hz vibration group, and in the second, seven subjects (mean age 23.3+/-3.8 years) participated in both 30 and 50 Hz vibration. Each subject's arm was passively vibrated for 10 minutes. SBF was examined during vibration and for 15 minutes of recovery.
Results
Both frequencies produced significant increases in SBF (p<0.05) within the first four minutes of vibration. Peak SBFs were obtained by the fifth minute. SBF remained high for minutes 4 through 10 of vibration in the second study. In the first study, SBF remained high for minutes 4 through 9. During recovery, 30 Hz vibration produced SBFs below baseline values while 50 Hz SBFs remained above baseline. Statistically one frequency was not superior to the other.
Conclusions
Five minutes of 30 Hz or 50 Hz vibration produced significant increases in SBF. Clinically, 50 Hz has additional benefits because SBF increased more rapidly and did not result in vasoconstriction during the recovery period. Future studies should be done to determine if these increases in SBF could be of benefit to populations with low circulation such as those with diabetes.
Keywords: Skin - blood supply, Regional Blood Flow, Vibration, Arm - blood supply, Adolescent
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Clinical Research
Impact of Nurse-Led Versus Surgeon-Led Preoperative Counseling and Follow-Up on Postoperative Outcomes in P...Med Sci Monit In Press; DOI: 10.12659/MSM.945597
Clinical Research
Evaluation of Attitudes to Learning Doctor-Patient Communication Skills in 427 Postgraduate Doctors Using t...Med Sci Monit In Press; DOI: 10.12659/MSM.947276
Clinical Research
Exploring the Association Between Serum Neurogranin, Nardilysin, and Ischemic Stroke: A Case-Control Study ...Med Sci Monit In Press; DOI: 10.12659/MSM.947703
Clinical Research
Comparative Analysis of Laser Therapies for Striae Distensae: Fractional COâ‚‚ vs Combined Q-Switch Nd:YAGMed Sci Monit In Press; DOI: 10.12659/MSM.947464
Most Viewed Current Articles
17 Jan 2024 : Review article 7,036,157
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,298
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,491
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 21,680
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912